compound glp 1 ban Eli Lilly strikes Zepbound deal with Ro, amid questions on compounded GLP-1s FDA is moving to restrict

The GLP-1 NAION vision-loss MDL hit 146 cases on the July JPML report up 70% in two months as the GI-injury MDL heads to Rule 702 hearings September 10-18.

New FDA regulations and legal actions are phasing out compounded GLP-1s, while companies introduce lower-priced, FDA-approved alternatives.

Health and wellness company Hims & Hers announced Monday that it is introducing injectable weight-loss drugs at a fraction of the cost of Ozempic and Wegovy.

In rare reports this can have serious or fatal outcomes * seek urgent medical attention if you experience severe, persistent abdominal pain, that may radiate to your back and may be accompanied by nausea and vomiting, as this may be a sign of pancreatitis * do not restart GLP-1 receptor agonist or GLP-1/GIP receptor agonist treatment if pancreatitis is confirmed * report suspected side effects through the Yellow Card scheme.

Alexy D